Showing 1 - 20 results of 28 for search 'Giovanni Luca Frassineti', query time: 0.06s
Refine Results
-
1
Takotsubo Syndrome (TTS) in Onco-Hematologic Patients: Retrospective Analysis and Focus on the Correlation or Not With Anticancer Drugs. Case Reports and Review of the Literature by Manlio Monti, Pietro Cortesi, Roberto Vespignani, Ilaria Bronico, Chiara Gallio, Michele Flospergher, Laura Matteucci, Giovanni Luca Frassineti
Published 2022-05-01
Article -
2
-
3
Circulating Plasma Levels of miR-20b, miR-29b and miR-155 as Predictors of Bevacizumab Efficacy in Patients with Metastatic Colorectal Cancer by Paola Ulivi, Matteo Canale, Alessandro Passardi, Giorgia Marisi, Martina Valgiusti, Giovanni Luca Frassineti, Daniele Calistri, Dino Amadori, Emanuela Scarpi
Published 2018-01-01
Article -
4
-
5
-
6
Hemophagocytic lymphohistiocytosis in gastric cancer: A rare syndrome for the oncologist. Case report and brief review by Manlio Monti, Giovanni Marconi, Andrea Ambrosini-Spaltro, Chiara Gallio, Virginia Ghini, Luca Esposito, Stefano Antonini, Daniela Montanari, Giovanni Luca Frassineti
Published 2023-02-01
Article -
7
Equivalent Efficacy but Different Safety Profiles of Gemcitabine Plus Nab-Paclitaxel and FOLFIRINOX in Metastatic Pancreatic Cancer by Ilario Giovanni Rapposelli, Andrea Casadei-Gardini, Caterina Vivaldi, Giulia Bartolini, Laura Bernardini, Alessandro Passardi, Giovanni Luca Frassineti, Valentina Massa, Alessandro Cucchetti
Published 2021-05-01
Article -
8
CNA Profiling of Single CTCs in Locally Advanced Esophageal Cancer Patients during Therapy Highlights Unexplored Molecular Pathways by Giulia Gallerani, Tania Rossi, Martina Valgiusti, Davide Angeli, Pietro Fici, Sara De Fanti, Erika Bandini, Claudia Cocchi, Giovanni Luca Frassineti, Massimiliano Bonafè, Francesco Fabbri
Published 2021-12-01
Article -
9
Performance indicators for monitoring the integrated care pathway of patients with colorectal cancer: the E.Pic.A. project by Andrea Ricotti, Giovanni Messori Ioli, Mattia Altini, Letizia Bachini, William Balzi, Giovanni Luca Frassineti, Fabrizio Gemmi, Ilaria Massa, Andrea Pierini, Oscar Bertetto, Patrizia Racca
Published 2019-06-01
Article -
10
Circulating VEGF and eNOS variations as predictors of outcome in metastatic colorectal cancer patients receiving bevacizumab by Giorgia Marisi, Emanuela Scarpi, Alessandro Passardi, Oriana Nanni, Angela Ragazzini, Martina Valgiusti, Andrea Casadei Gardini, Luca Maria Neri, Giovanni Luca Frassineti, Dino Amadori, Paola Ulivi
Published 2017-05-01
Article -
11
Cytoreduction plus hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis in colorectal cancer patients: a single-center cohort study by Leonardo Solaini, Fabrizio D’Acapito, Alessandro Passardi, Massimo Framarini, Francesca Tauceri, Daniela Di Pietrantonio, Giovanni Luca Frassineti, Andrea Casadei Gardini, Alessandro Cucchetti, Davide Cavaliere, Giorgio Ercolani
Published 2019-03-01
Article -
12
Association between Pre-Treatment Biological Indicators and Compliance to Neoadjuvant/Perioperative Chemotherapy in Operable Gastric Cancer by Manlio Monti, Andrea Prochowski Iamurri, David Bianchini, Chiara Gallio, Luca Esposito, Daniela Montanari, Silvia Ruscelli, Chiara Molinari, Flavia Foca, Alessandro Passardi, Giovanni Vittimberga, Paolo Morgagni, Giovanni Luca Frassineti
Published 2023-08-01
Article -
13
Heterogeneity of Response and Immune System Activity during Treatment with Nivolumab in Hepatocellular Carcinoma: Results from a Single-Institution Retrospective Analysis by Ilario Giovanni Rapposelli, Serena De Matteis, Paola Lanuti, Martina Valgiusti, Giulia Bartolini, Paola Ulivi, Giorgia Marisi, Federica Pedica, Valentina Burgio, Giovanni Luca Frassineti, Stefano Cascinu, Andrea Casadei-Gardini
Published 2021-01-01
Article -
14
An Integrated Model to Improve Medication Reconciliation in Oncology: Prospective Interventional Study by Alessandro Passardi, Patrizia Serra, Caterina Donati, Federica Fiori, Sabrina Prati, Roberto Vespignani, Gabriele Taglioni, Patrizia Farfaneti Ghetti, Giovanni Martinelli, Oriana Nanni, Mattia Altini, Giovanni Luca Frassineti, Martina Vittoria Minguzzi
Published 2021-12-01
Article -
15
Effectiveness of bevacizumab in first- and second-line treatment for metastatic colorectal cancer: ITACa randomized trial by Elisabetta Petracci, Emanuela Scarpi, Alessandro Passardi, Annibale Biggeri, Carlo Milandri, Stefano Vecchia, Fabio Gelsomino, Davide Tassinari, Stefano Tamberi, Ilaria Bernardini, Caterina Accettura, Giovanni Luca Frassineti, Dino Amadori, Oriana Nanni
Published 2020-07-01
Article -
16
<sup>1</sup>H-NMR Based Serum Metabolomics Highlights Different Specific Biomarkers between Early and Advanced Hepatocellular Carcinoma Stages by Andrea Casadei-Gardini, Laura Del Coco, Giorgia Marisi, Fabio Conti, Giulia Rovesti, Paola Ulivi, Matteo Canale, Giovanni Luca Frassineti, Francesco Giuseppe Foschi, Serena Longo, Francesco Paolo Fanizzi, Anna Maria Giudetti
Published 2020-01-01
Article -
17
Chemoradiotherapy (Gemox Plus Helical Tomotherapy) for Unresectable Locally Advanced Pancreatic Cancer: A Phase II Study by Alessandro Passardi, Emanuela Scarpi, Elisa Neri, Elisabetta Parisi, Giulia Ghigi, Giorgio Ercolani, Andrea Gardini, Giuliano La Barba, Flavia Pagan, Andrea Casadei-Gardini, Martina Valgiusti, Fabio Ferroni, Giovanni Luca Frassineti, Antonino Romeo
Published 2019-05-01
Article -
18
Erratum: Passardi, A. et al. Chemoradiotherapy (Gemox Plus Helical Tomotherapy) for Unresectable Locally Advanced Pancreatic Cancer: A Phase II Study. <i>Cancers</i> 2019, <i>11</i... by Alessandro Passardi, Emanuela Scarpi, Elisa Neri, Elisabetta Parisi, Giulia Ghigi, Giorgio Ercolani, Andrea Gardini, Giuliano La Barba, Flavia Pagan, Andrea Casadei-Gardini, Martina Valgiusti, Fabio Ferroni, Giovanni Luca Frassineti, Antonino Romeo
Published 2020-01-01
Article -
19
Analysis of EVs from patients with advanced pancreatic cancer identifies antigens and miRNAs with predictive value by Ivan Vannini, Tania Rossi, Mattia Melloni, Martina Valgiusti, Milena Urbini, Alessandro Passardi, Giulia Bartolini, Chiara Gallio, Irene Azzali, Sara Bandini, Valentina Ancarani, Lorenzo Montanaro, Giovanni Luca Frassineti, Francesco Fabbri, Ilario Giovanni Rapposelli
Published 2023-06-01
Article -
20
Prospective validation of VEGF and eNOS polymorphisms as predictors of first-line bevacizumab efficacy in patients with metastatic colorectal cancer by Giorgia Marisi, Irene Azzali, Alessandro Passardi, Francesca Rebuzzi, Giulia Bartolini, Milena Urbini, Matteo Canale, Chiara Molinari, Laura Matteucci, Francesco Giulio Sullo, Silvia Angela Debonis, Chiara Gallio, Graziana Gallo, Giovanni Luca Frassineti, Paola Ulivi
Published 2023-08-01
Article